Clarification of transcellular transport mechanism of drugs utilizing tissue cultured cell systems
利用组织培养细胞系统阐明药物的跨细胞转运机制
基本信息
- 批准号:04452305
- 负责人:
- 金额:$ 4.29万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1993
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Tissue cultured cells, which retain energy-dependent transport and metabolic functions in vivo, are useful as in vitro model to investigate drug transport at the cellular level. The purpose of the present research is to prove, by utilizing proper cultured cell systems, our new hypotheses, which are different from the passive diffusion mechanism for drug transports through the intestinal epithelial cells and brain capillary endothelial cells. The following results including several new findings were obtained :1)Utilizing cultured human intestinal cell line Caco-2, we have successfully proved that characteristics of the apical to basolateral transepithelial transport of [^<14>C]benzoic acid and[^<14>] salicylic acid in Caco-2 are very similar to those obtained for intestinal brush-border membrane vesicle and that the pH dependent intestinal-absorption of weak-acidic drugs is attributed not to the previously believed "pH-partition theory" but to "protoncoupled and carrier-mediated transpo … More rt" for monocarboxylic acids.2)A heterologous gene expression system, Xenopus laevis oocytes injected with mRNA from the intestinal mucosa, were used to prove the carrier-mediated transport of beta-lactam amtibiotics in small intestine. As the results, the intestinal transport of zwitterionic and dicarboxylic-acid beta-lactam antibiotics was confirmed to be mediated by a specialized transport system which is common to dipeptides. beta-lactam antibiotics were also to be transported by carrier-mediated mechanisms in rabbits and humans as well as rats.3)The uptake of [^3H]vincristine (VCR) and [^3H]cyclosporin A(CsA) by cultured monolayrs of bovine brain capillary endothelial cells (BCECs), which express P-glycoprotein (P-gp) at the luminal membrane sruface, was significantly enhanced by treatment of MDR reversing agents, an anti-P-gp monoclonal antibody and metabolic inhibitors. These results indicate that low permeability of VCR and CsA into the brain is caused by the active efflux from BCEC by P-gp and suggest that P-gp functions as blood-brain barrier for lipophilic and cytotoxic comounds. Less
组织培养的细胞在体内保持能量依赖性转运和代谢功能,可用作研究细胞水平药物转运的体外模型。本研究的目的是利用适当的培养细胞系统来证明我们的新假说,即药物通过肠上皮细胞和脑毛细血管内皮细胞转运的被动扩散机制不同。结果表明:1)利用培养的人小肠细胞系Caco-2,我们成功地证明了[^<14>C]苯甲酸和[^<14>]水杨酸在Caco-2中的跨上皮转运特性与在小肠刷状缘膜囊泡中获得的转运特性非常相似,并且弱酸性药物的pH依赖性药物吸收不是以前认为的“pH分配理论”,而是“质子耦合和载体-中介转运 ...更多信息 (2)利用外源基因表达系统--非洲爪蟾卵母细胞注射肠粘膜mRNA,证明β-内酰胺类抗生素在小肠中的载体介导转运。结果证实,两性离子和二羧酸β-内酰胺抗生素的肠道转运是由二肽共有的专门转运系统介导的。β-内酰胺类抗生素在兔、人和大鼠中也通过载体介导的机制转运。3)培养的单层牛脑毛细血管内皮细胞(BCEC)对[^3H]长春新碱(VCR)和[^3H]环孢菌素A(CsA)的摄取通过MDR逆转剂处理显著增强,BCEC在管腔膜表面表达P-糖蛋白(P-gp),抗P-gp单克隆抗体和代谢抑制剂。这些结果表明VCR和CsA进入脑的低渗透性是由P-gp从BCEC主动外排引起的,并表明P-gp作为亲脂性和细胞毒性化合物的血脑屏障发挥作用。少
项目成果
期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Tsuji,et al.: "Transport mechanism of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors at the blood-brain barrier" J.Pharmacol.Exp.Ther.267. 1085-1090 (1993)
A.Tsuji 等人:“3-羟基-3-甲基-戊二酰辅酶 A 还原酶抑制剂在血脑屏障中的转运机制”J.Pharmacol.Exp.Ther.267。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A.Tsuji: "P-glycoprotein and blood-brain barrier (II)" Molecular Medicine. 30. 748-755 (1993)
A.Tsuji:“P-糖蛋白和血脑屏障(II)”分子医学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A.Tsuji,et al.: "P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells" Life Sci.51. 1427-1437 (1992)
A.Tsuji 等人:“P-糖蛋白作为原代培养的牛脑毛细血管内皮细胞中的药物流出泵”Life Sci.51。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
寺崎哲也,他: "ペプチド性薬物およびオリゴヌクレオチドの脳へのデリバリー" BIOmedica. 8. 396-400 (1993)
Tetsuya Terasaki 等人:“向大脑递送肽药物和寡核苷酸”BIOmedica。 8. 396-400 (1993)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A.Tsuji,et al.: "Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter,P-glycoprotein" Biochem.Pharmacol.46. 1096-1099 (1993)
A.Tsuji 等人:“多药转运蛋白 P-糖蛋白限制环孢菌素 A 穿过血脑屏障”Biochem.Pharmacol.46。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUJI Akira其他文献
TSUJI Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUJI Akira', 18)}}的其他基金
The Application of 'Passport' and 'Gateway' Proteins to the Absorption, Distribution, Excretion and Delivery of Drugs
“护照”和“门户”蛋白在药物吸收、分布、排泄和递送中的应用
- 批准号:
16390039 - 财政年份:2004
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Drug Delivery based on Multiplicity of Various Membrane Transporters
基于多种膜转运蛋白的药物递送
- 批准号:
12307057 - 财政年份:2000
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Delivery of peptide-mimetic drugs to tumors utilizing oligopeptide transporters
利用寡肽转运蛋白将肽模拟药物递送至肿瘤
- 批准号:
12557204 - 财政年份:2000
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Drug deliver by utilization of tissue specific transportes.
通过利用组织特异性运输来递送药物。
- 批准号:
10470510 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Intestinal absorption of drugs mediated by transporters in intestinal epithelial cells
肠上皮细胞转运蛋白介导的药物肠道吸收
- 批准号:
10557214 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clarification of organ specific transport mechanism of druge and its application to regulation of pharmacokinetics and pharmacodynamics
阐明药物的器官特异性转运机制及其在药代动力学和药效学调控中的应用
- 批准号:
07307035 - 财政年份:1995
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Blood-brain barrier functioning as dynamic interface and drug delivery to the brain
血脑屏障充当动态界面和向大脑输送药物
- 批准号:
07457527 - 财政年份:1995
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Quantitative analysis of factors determining age-related change in tissue distribution of animicrobial agents
确定抗菌剂组织分布随年龄变化的因素的定量分析
- 批准号:
61571094 - 财政年份:1986
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Modulation of Monocarboxylic Acid Transporter Kinetic Function for Stroke Therapy
用于中风治疗的单羧酸转运蛋白动力学功能的调节
- 批准号:
7980693 - 财政年份:2010
- 资助金额:
$ 4.29万 - 项目类别:
Prediction of Oral Absorption of Anionic Drugs that are Absorbed by the Monocarboxylic Acid Transport System
一元羧酸转运系统吸收的阴离子药物的口服吸收预测
- 批准号:
14572097 - 财政年份:2002
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction of Oral Absorption of Anionic Drugs that are Absorbed by the Monocarboxylic Acid Transport System
一元羧酸转运系统吸收的阴离子药物的口服吸收预测
- 批准号:
11672216 - 财政年份:1999
- 资助金额:
$ 4.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
2883737 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
6363924 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
6165267 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
6357603 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
2680955 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
6531083 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别:
MODULATION OF MONOCARBOXYLIC ACID TRANSPORTERS IN BRAIN
脑中单羧酸转运蛋白的调节
- 批准号:
6149443 - 财政年份:1998
- 资助金额:
$ 4.29万 - 项目类别: